Published January 1, 2018
| Version v1
Journal article
Open
EurA1c: The European HbA1c Trial to Investigate the Performance of HbA1c Assays in 2166 Laboratories across 17 Countries and 24 Manufacturers by Use of the IFCC Model for Quality Targets
Creators
- Weykamp, Cas1
- John, W. Garry2
- English, Emma3
- Erasmus, Rajiv T.4
- Sacks, David B.5
- Buchta, Christoph6
- Mueller, Mathias M.6
- Lenga, Yolande7
- Budina, Marek8
- Kratochvila, Josef8
- Friedecky, Bedrich8
- Siest, Jean-Pascal9
- Kaiser, Patricia10
- Haliassos, Alexander11
- Panagiotakis, Otto11
- Makris, Konstantinos11
- Graham, Hazel12
- Kane, Anne12
- Smith, Thomas P.12
- Barrett, Ned12
- Barrett, Ned12
- 1. Queen Beatrix Hosp, Winterswijk, Netherlands
- 2. Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
- 3. Univ East Anglia, Norwich, Norfolk, England
- 4. Tygerberg Hosp, Tygerberg, South Africa
- 5. NIH, Washington, DC USA
- 6. OQUASTA, Vienna, Austria
- 7. WIV ISP, Brussels, Belgium
- 8. SEKK, Pardubice, Czech Republic
- 9. Biol Prospect, Villers Les Nancy, France
- 10. INSTAND, Dusseldorf, Germany
- 11. ESEAP Gen Hosp, Athens, Greece
- 12. IEQAS, Dublin, Ireland
Description
BACKGROUND: A major objective of the IFCC Committee on Education and Use of Biomarkers in Diabetes is to generate awareness and improvement of HbA1c assays through evaluation of the performance by countries and manufacturers.
Files
bib-b1d67b2b-5fc5-4b79-95bc-8e110a2e866c.txt
Files
(488 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:859c142ec3963aa021a2618faf4ef3ac
|
488 Bytes | Preview Download |